Alpha Source - DBA Alpha Isotopes

The Alpha Source, Inc (DBA Alpha Isotopes) is an early stage company that has developed a new technology to create radioisotopes. This patented technology will not only allow the Company to produce widely used radioisotopes at a significantly lower cost than current producers, but it will also enable the development of new radioisotopes that have, to date, been too costly to produce for commercial purposes. The Company’s distinct competitive advantage is due to its breakthrough particle beam technology that generates alpha particles at levels thousands of times greater than any existing particle source. A wide range of radioisotopes can be produced by accelerating this high volume of alpha particles and colliding them into various elements. The Company has been awarded multiple patents covering its technology which has created significant barriers to entry. No other production method comes close to the yield, performance, cost, reliability, flexibility, and eco-friendliness. The Company’s ability to produce several otherwise unavailable or economically unfeasible radioisotopes will expand the market and enable the development of radiopharmaceutical for personalized cancer therapies, e.g., Ac-225, Lu-177 (nca), Cu-67, At-211 & Sn-117m. Once the Company begins its operations, management expects the emergence of these new therapeutic radiopharmaceuticals to be rapid.